GSK and CureVac are planning further patient trials of their messenger RNA vaccines for flu and Covid-19 after promising early results https://t.co/uGp5rvFCjV— Bloomberg (@business) January 6, 2023
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


